News: InfectoGnostics Forschungscampus

Consistently positive response at the joint Thuringian diagnostics stand at MEDICA 2023

The two Thuringian innovation clusters Medways and InfectoGnostics organized a joint stand for the first time in the Diagnostics Hall 3

11/20/2023

Austausch zwischen LifeScience-Experten aus Norditalien mit der Landesentwicklungsgesellschaft Thüringen und dem Forschungscampus InfectoGnostics in Modena und Mailand.

Thuringia's life sciences sector intensifies international cooperation in northern Italy

From October 2 to 5, 2023, the State Development Agency of Thuringia (LEG) together with the InfectoGnostics Research Campus presented the Thuringian life sciences sector during a trip to Italy. The trip was supported by Germany Trade and Invest (GTAI) and organized by the Italian Chamber of…

10/16/2023

[Translate to English:] Das Gyntect-Testkit der Firma oncgnostics: Mit dem epigenetischen Test lassen sich Krebsvorstufen früh erkennen.

Hong-Kong Firm invests in Jena-Based Ongnostics GmbH

The Hong Kong-based company Grande Bio-tech Co. Ltd. is making a multi-million Euros investment in the Jena-based diagnostic company Oncgnostics GmbH. Oncgnostics – an InfectoGnostics partner – has developed the cancer diagnostic Gyntect for the reliable detection of cervical cancer. The goal now is…

09/06/2023

Visitors at the Blink AG booth at the AACC & Clinical Lab Expo 2023 in Anaheim, CA, USA

"Blink One" presentation at AACC: Campus partner BLINK DX introduces open diagnostics platform in the U.S.

InfectoGnostics partner BLINK DX presented its new "Blink One" diagnostic platform in Anaheim, California, at the annual meeting of the American Association for Clinical Chemistry (AACC). The new platform enables very fast digital PCR (dPCR) in a few minutes without microfluidics and allows the…

07/31/2023

Future with biotechnology: InfectoGnostics at the Unternehmer:innentag 2023 of BIO Deutschland

Entrepreneurs from the innovative biotechnology sector entered into an exchange with politicians at the Unternehmer:innentag 2023 of BIO Deutschland e.V. in Berlin on July 5, 2023.

07/05/2023

KIT 2023 in Leipzig: Dr. Stefan Monecke präsentiert die aktuelle Forschung zu PVL-produzierenden Staphylokokken aus der Karibik.

InfectoGnostics study on spread of Staphylococcus aureus strains in the Caribbean.

The facultatively pathogenic and often (multi-)resistant bacterium Staphylococcus aureus causes a large proportion of hospital infections worldwide. InfectoGnostics researchers from the Leibniz Institute for Photonic Technology (Leibniz-IPHT) were able to extensively molecularly characterize strains…

07/04/2023

InfectoGnostics partner "Dynamic42" raises mid-seven-figure investment in Series A financing round

Organ-on-chip specialist Dynamic42 GmbH has closed a mid-seven-figure financing round. The company, which was spun off from the "Center of Sepsis Control and Care" of the University Hospital Jena in March 2018, was able to convince both the previous lead investor bm-t beteiligungsmanagement…

06/13/2023

Market introduction and reimbursement: workshop for young EU researchers

On May 11, 2023, international Early Stage Researchers of the PHAST-ETN participated in a joint workshop of Leibniz Health Technologies with the InfectoGnostics Research Campus Jena as part of an engagement week at the Center for Applied Research of the Friedrich Schiller University Jena.

05/12/2023

InfectoGnostics and Partner Nanozoo at DMEA 2023 fair in Berlin

From April 25 to 27, the Digital Medical Expertise & Applications (DMEA), Europe's largest trade fair event in the field of digitalized healthcare, was held in Berlin. Our research campus partner Nanozoo presented itself with an appearance at the Thuringian joint booth.

05/05/2023

New spokesperson team of the BioRegions working group elected

Dr. Julia Schaft from BioRN is supported as the new spokesperson of the BioRegions working group by Dr. Jürgen Walkenhorst LifeScience Nord and Dr. Jens Hellwage (InfectoGnostics/Thuringia).

03/30/2023